A&O Shearman advises Partners Group on the financing for its acquisition on behalf of its clients of a majority stake in FairJourney Biologics

FairJourney Biologics is a leading antibody discovery Contract Research Organization supporting pharmaceutical and biotech companies working at the cutting edge of innovation to develop the next generation of antibody-based therapies.

The team was led by sponsor side leveraged finance partners Neil Sinha (private equity sector lead (Europe)) and Nick Hallam, together with senior associate Tiffany Liow, associates Ramone Bedi and Jack Mellett and trainee Nicholas Ho.